Oral azithromycin for treatment of intractable rosacea

Journal of Korean Medical Science

Volumn 26, Issue 5, 2011, Pages 694-696

  Kim, Jae Hong ^a   Oh, Yoon Seok ^a   Choi, Eung Ho ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

Azithromycin; Rosacea

Indexed keywords

AZITHROMYCIN; REACTIVE OXYGEN METABOLITE;

ARTICLE; CASE REPORT; ERYTHEMA; FEMALE; HUMAN; MIDDLE AGED; ORAL DRUG ADMINISTRATION; ROSACEA; SKIN DISEASE;

ADMINISTRATION, ORAL; AZITHROMYCIN; ERYTHEMA; FEMALE; HUMANS; MIDDLE AGED; REACTIVE OXYGEN SPECIES; ROSACEA; SKIN DISEASES;

EID: 79955642422     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2011.26.5.694     Document Type: Article

References (17)

1. Modi S, Harting M, Rosen T. Azithromycin as an alternative rosacea therapy when tetracyclines prove problematic. J Drugs Dermatol 2008; 7: 898-9.
2. James WD, Berger TG, Elston DM. Andrew's diseases of the skin. 10th ed. Philadelphia: WB Sauders 2006; 245-9.
3. Del Rosso JQ. Systemic therapy for rosacea: focus on oral antibiotic therapy and safety. Cutis 2000; 66 (4 Suppl): 7-15.
4. Bakar O, Demirçay Z, Gürbüz O. Terapeutic potential of azithromycin in rosacea. Int J Dermatol 2004; 43: 151-4.
5. Fernandez-Obregon A. Oral use of azithromycin for the treatment of acne rosacea. Arch Dermatol 2004; 140: 489-90.
6. Fernandez-Obregon A, Patton DL. Te role of Chlamydia pneumoniae in the etiology of acne rosacea: response to the use of oral azithromycin. Cutis 2007; 79: 163-7.
7. Bakar O, Demirçay Z, Yuksel M, Haklar G, Sanisoglu Y. The effect of azithromycin on reactive oxygen species in rosacea. Clin Exp Dermatol 2007; 32: 197-200.
8. Jones D. Reactive oxygen species and rosacea. Cutis 2004; 74 (3 Suppl): 17-20.
9. Humbert P, Trefel P, Chapuis JF, Buchet S, Derancourt C, Agache P. Te tetracyclines in dermatology. J Am Acad Dermatol 1991; 25: 691-7.
10. Bannatyne RM. Metronidazole, its bioactive metabolites and acne. Curr Med Res Opin 1999; 15: 298-9.
11. Labro MT. Anti-inflammator y activity of macrolides: a new therapeutic potential? J Antimicrob Chemother 1998; 41 Suppl B: 37-46.
12. McDonald PJ, Pruul H. Phagocyte uptake and transport of azithromycin. Eur J Clin Microbiol Infect Dis 1991; 10: 828-33.
13. Scaglione F, Rossoni G. Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarithromycin. J Antimicrob Chemother 1998; 41 Suppl B: 47-50.
14. Alvarez-Elcoro S, Enzler MJ. The macrolides: erythromycin, clarithromycin, and azithromycin. Mayo Clin Proc 1999; 74: 613-34.
15. Akhyani M, Ehsani AH, Ghiasi M, Jafari AK. Comparison of efficacy of azithromycin vs. doxycycline in the treatment of rosacea: a randomized open clinical trial. Int J Dermatol 2008; 47: 284-8.
16. Torresani C. Clarithromycin: a new perspective in rosacea treatment. Int J Dermatol 1998; 37: 347-9.
17. Dereli T, Inanir I, Kilinç I, Gençoǧlan G. Azithromycin in the treatment of papulopustular rosacea. J Dermatol 2005; 32: 926-8.